Q: Thoughts on the Q and go forward outlook.
Thanks!!
Thanks!!
5i Research Answer:
EPS of $1.12 matched estimates; revenue of $1.49B was marginally better than $1.48B expected. EBITDA of $247M was 2% short of estimates. 2024 sales guidance was raised to 12% to 15% from 11% to 15%. Backlog is $7.2B, up 13.4%. Sales rose 16%. EPS rose 13%. Organic growth was solid at 7.7%. Not 'perfect' but we would still consider the quarter good and the outlook also looks fine based on management comments.